Management of Contaminated Autologous Grafts in Plastic Surgery by Centeno, Robert F et al.
Management of Contaminated Autologous Grafts
in Plastic Surgery
Robert F. Centeno, MD, MBA,a Ankit R. Desai, MD,b and Marla E. Watson, MAc
aSaintCroixPlasticSurgery&MediSpa,Christiansted,USVirginIslands00824; bDivisionofPlastic
and Reconstructive Surgery, St Louis University, St Louis, Missouri; and cBody Aesthetic Plastic
Surgery & Skincare Center, St Louis, Missouri
Correspondence: rfcenteno@gmail.com
Published April 22, 2008
Background: Contamination of autologous grafts unfortunately occurs in plastic
surgery, but the literature provides no guidance for management of such incidents.
Methods: American Society of Aesthetic Plastic Surgery members were asked to com-
plete an online survey that asked about the number and causes of graft contaminations
experienced, how surgeons dealt with the problem, the clinical outcomes, and patient
disclosure. Results: Nineteen hundred surgeons were asked to participate in the survey,
and 223 responded. Of these, 70% had experienced at least 1 graft contamination inci-
dent, with 26% experiencing 4 or more. The most frequently reported reason for graft
contamination was a graft falling on the floor (reported by 75%). Nearly two thirds of
the contaminated grafts related to craniofacial procedures. Ninety-four percent of grafts
were managed with decontamination and completion of the operation. The most com-
mon method of decontamination was washing with povidone-iodine, but this practice
is contrary to recommendations in the literature. Only 3 surgeons (1.9%) said a clinical
infection developed following decontaminated graft use. Patients were not informed in
60% of graft contamination incidents. The survey results and review of the literature led
to development of algorithms for the management of inadvertent graft contamination
and patient disclosure. Conclusions: Although autologous grafts do become contami-
nated in plastic surgery, the overwhelming majority can be safely decontaminated and
produce minimal or no clinical sequelae. The algorithms presented are intended to serve
as guides for prevention of contamination events or for their management should they
occur.
The use of autologous grafts in aesthetic and reconstructive surgery has become in-
creasingly common, especially with the growing popularity of fat and cartilage autografts
in facial and nasal surgery. However, as with any technique innovation, the benefits come
with some potential risks. Since contaminated grafts have the potential to grow bacteria,
patients who receive them are theoretically placed at increased risk for infection.
None of the authors have any financial interests or relationships related to the subject of this article. Hosting
the survey on Survey Monkey was paid for by Dr Centeno’s private practice.
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This study was designed to survey plastic surgeons on their practices following inad-
vertent contamination of autografts. A literature review also was conducted to learn what
others recommend for handling such incidents. The survey results and published litera-
ture provide a basis for developing algorithms intended to guide surgeons in managing the
contamination of a variety of autograft types used in plastic surgery.
METHODS
We developed a questionnaire for which a Web link was sent via e-mail by the Aesthetic
Surgery Education and Research Foundation to members of the American Society of Aes-
thetic Plastic Surgery (ASAPS). Members were asked to participate in the survey and
assured that their responses would be anonymous. The Web link connected surgeons to
an 11-question online survey, shown in Figure 1, that was hosted by Survey Monkey
(www.surveymonkey.com), a data collection and analysis company. The questionnaire was
designedtoobtaininformationonautograftcontaminationfrequency,treatmentpreferences,
clinical outcomes, and patient disclosure.
Inconjunctionwiththesurvey,PubMedwassearchedforpublishedliteraturerelatedto
contamination of fat, skin, cartilage, composite tissue, and bone grafts, as well as proposed
management strategies and appropriate decontamination techniques.
RESULTS
Although 1900 ASAPS members were invited to participate in this anonymous online
survey, only 223 surgeons (12%) submitted the questionnaire. The survey began by asking
how long surgeons have been in practice. Of the 223 responders, 87% have been practicing
for 10 or more years, with 65% in practice for more than 16 years.
Surgeons were then asked whether they had witnessed or experienced a graft contam-
ination. The 30% of respondents who answered “no” were directed to stop and submit the
survey. The 70% who said they had experienced a graft contamination represents at least
157 surgeons; however, there was a 3-surgeon inconsistency, with 160 answering questions
that specifically asked about contamination experience. It seems that 3 surgeons who an-
swered “no” on question 2 should have checked “yes” because they did, in fact, have graft
contamination experience.
Reasonsforthelow(12%)responserateareunknown.Surgeonsmaynothavehadtime
tocompleteitorwerenotinterestedinthetopic.Anotherpossibilityisthatsurgeonsdidnot
want to admit (even anonymously) that they have had a graft contamination incident. The
fact that 87% of respondents have been in practice for at least 10 years may reflect a greater
willingness to admit unintentional errors by more experienced surgeons. Because of the
low response rate, the survey cannot be viewed as representative of all ASAPS members.
Nevertheless, the results offer some interesting information about an issue not previously
reported in the literature and rarely discussed openly by colleagues.
Among survey respondents, 70.4% (n = 157) reported either witnessing or experi-
encing graft contamination during a plastic surgery procedure. As shown in Table 1, 33%
of surgeons reported 2 occurrences, and almost 26% experienced 4 or more contaminated
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Figure 1. Survey sent to plastic surgeons on management of contaminated grafts.
(Continues)
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Figure 1. (Continued)
Table 1. Numberofgraftcontaminationsreported
by 156 surgeons with contamination experience
No. of incidents No. of Surgeons (%)
1 43 (27.5)
2 52 (33.3)
3 21 (13.5)
4 11 (7.1)
5 2 (1.3)
>5 27 (17.3)
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Table 2. Causes of graft contaminationa
Percentage of surgeons
reporting this experience
Graft/flap fell on floor 75
Exposure to nonsterile part of field/drape 44.3
Exposure to contaminated part of operating field (ear, nasopharynx,
anorectal, genitourinary)
28.7
Graft/flap discarded in trash 28.1
Exposure to nonsterile specimen container/suction
catheter-canister/instrument
16.9
Other 1.9
aMultiple responses allowed. Data for 312 contamination incidents reported by 160 surgeons.
Table 3. Anatomical area where graft was to be placeda
Anatomical area Response, % (no. of experiences)
Craniofacial 65.8 (104)
Lower extremity 27.2 (43)
Breast 25.3 (40)
Trunk 17.7 (28)
Upper extremity 17.1 (27)
Genitourinary 2.5 (4)
aMultiple responses allowed. Data for 246 contamination incidents reported by 158 surgeons.
graft incidents. The reporting of 2 instances by 52 surgeons represents 104 contaminations.
If this mathematical exercise is continued and the “more than 5” response is assumed to be
6, then the total number of contaminated graft experiences is at least 426 among the 156
surgeons who answered this question.
Multipleresponseswereallowedformanysurveyquestionstocaptureafullerrangeof
experience for each surgeon. The most frequent method of contamination, reported by 75%
of respondents, was a graft or flap falling on the floor (Table 2). A distant second, at 44%,
was exposure to a nonsterile part of the field/drape. All other reasons for contamination
shown in Table 2 are equally accidental.
The predominant anatomical site undergoing surgery at the time of autograft contam-
ination was the craniofacial region, at 66% (Table 3). This may be because craniofacial
grafts tend to be very small and therefore may be more easily knocked off a table or thrown
in the trash. Contamination also occurs in autografts of the lower extremity, breast, trunk,
upper extremity, and genitourinary areas.
Table 4 shows the types of contaminated autografts. Skin grafts received the most
responses (61%), followed by cartilage grafts at 39%. Nipple-areolar complex grafts and
bone grafts were the only other types reported by more than 20% of respondents.
No surgeon abandoned a procedure after graft contamination. Instead, 94% decontam-
inatedthegraftandproceededwiththeirsurgicalplan(Table5).Only7%harvestedanother
graft, 4% used another reconstructive technique, and 2% substituted alloplastic material.
The methods of decontamination are shown in Table 6, with the favored techniques being
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Table 4. Contamination incidents by graft typea
Graft/ﬂap type Response, % (no. of experiences)
Skin 61.4 (97)
Cartilage 39.2 (62)
Nipple-areolar complex 22.2 (35)
Bone 21.5 (34)
Composite flap/graft 12.7 (20)
Muscle 11.4 (18)
Fascia 7.6 (12)
Fat 3.8 (6)
*Multiple responses allowed. Data for 284 contamination incidents reported by 158 surgeons.
Table 5. Management of contaminated grafta
Response, % (no. of experiences)
Graft/flap irrigated/decontaminated and used 94.4 (151)
Graft/flap harvested from alternate site other 6.9 (11)
than operative field
Other reconstructive technique used 3.8 (6)
Alloplastic material/implant substituted 1.9 (3)
Graft/flap discarded and operation ended 0
aMultiple responses allowed. Data for 160 reporting surgeons.
Table 6. Decontamination technique employed if graft was useda
Method Response, % (no. of experiences)
Povidone-Iodine 54.1 (85)
Antibiotic solution 50.3 (79)
Bulb saline irrigation 42.7 (67)
Pulse/lavage saline irrigation 11.5 (18)
Other (please specify) 3.8 (6)
None 3.2 (4)
Chlorhexidine gluconate 0.6 (1)
aMultiple responses allowed. Data for 260 contamination incidents reported by 157 surgeons.
the use of povidone-iodine (polyvinyl pyrrolidone or PVP-I) (54%) or antibiotic solution
(50%). Responses to the “other” category for this question included the use of systemic
antibiotics or washing the graft with other agents.
Morethan98%ofrespondentswhohadcontaminatedgraftexperiencesaidthatitsuse
did not, to their knowledge, lead to an infection. Three decontaminated grafts (1.9%) were
associated with clinical infection, but this infection rate is comparable to that reported for
cleannoncontaminatedsurgicalcases.1 Onesurgeondidnotspecifythelocation,1reported
a systemic infection, and the third, a surgical site infection. Two of these surgeons had used
PVP-I and 1 used bulb saline with antibiotic solution for decontamination.
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Table 7. Contamination incident disclosure
Response, % (no. of experiences)
Incident not disclosed 60 (96)
Chart notation/incident report made 25 (40)
Patient/family informed postoperatively 20.6 (33)
Risk discussed as part of informed consent 11.9 (19)
Other 3.8 (6)
aMultiple responses allowed. Data reported by 160 surgeons.
Sixty percent of responding surgeons did not disclose the contamination incident to
patients. Other actions taken are shown in Table 7, but only 21% said they had informed the
patient/family postoperatively. The survey choice of “chart notation/incident report made”
(selected by 25% of respondents) was poorly phrased because a chart notation is quite
different from submitting an incident report to the surgical facility. One respondent noted
that 1 incident was not disclosed because the possibility had been discussed in the informed
consentprocess,butinanothercasethepatientwastoldbecausetheconsentdidnotmention
this possibility.
DISCUSSION
Inadvertent contamination of autografts presents a dilemma for surgeons, yet the plastic
surgery literature lacks specific discussions of clinical experience with the management
or outcome of contaminated grafts. Although our search for relevant articles focused on
autografts, bone and tendon allografts have been studied more than other types, with much
of the literature appearing in orthopedic journals. Most of articles described either in vitro
experimentsorinvivoanimalstudiesofsterilizationagentsusedafterintentionalmicrobial
inoculation. Extrapolating data from such experiments to clinical practice is difficult.
In our survey, the most common source of contamination resulted from a graft falling
on the floor. Several investigations have cultured grafts intentionally dropped and left on an
operating room (OR) floor for as little as 15 seconds. Although one study found no positive
results of cultures on contaminated samples,2 others reported that between 58% and 96%
of dropped grafts became contaminated.3–5 As proof of the risk to which patients may be
exposed, 90% of rabbits receiving uncleansed contaminated grafts developed infections.6
The literature agrees that a dropped graft can be safely used if sterilized before place-
ment. Among survey respondents, more than 94% did decontaminate and use the graft.
Harvesting another graft is often not a practical option and/or can cause additional mor-
bidity. Substitute alloplastic material may not be available, and obtaining an allograft can
take days; furthermore, either of these approaches would require patient consent. Thus,
abandoning a procedure with the idea of rescheduling later is impractical and probably not
in the best interests of patients.
Povidone-Iodine
The graft decontamination agent used by a majority of survey respondents (54%) was PVP-
I. However, much of the literature suggests this readily available solution is not the best
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choice.SomecomparisonstudiesfoundPVP-Itobeeffectiveforbonecontamination,7,8 yet
one of these concluded that 10% PVP-I did not completely decontaminate femoral heads,
and higher levels of contamination with Staphylococcus epidermidis required more than
10 minutes of soaking.8
The antimicrobial effectiveness of PVP-I has been challenged by Stanford and
colleagues,9 whofoundthat10%PVP-Ididnotdecontaminatecadaverpatellarbone-tendon
autografts even after 30 minutes of soaking or washing with agitation. Other studies com-
paring different antimicrobials and antiseptics determined that PVP-I was either ineffective
or the least effective decontaminate tested.5,10
Some decontamination experiments have concluded that PVP-I and chlorhexidine
gluconate (CGH [Hibiclens]) are toxic to bone cells, even at low concentrations of 1%.11
Although both agents reduced the number of bacterial colony counts, both also decreased
the number of osteoclasts and impaired osteoblast function, as did bacitracin (Bacitracin)
wash. Another study concluded that concentrations higher than 5% PVP-I were toxic to
osteoblasts and intact tibiae at 2 minutes of exposure.12 In this study, however, bacitracin
was not cytotoxic.
PVP-I also may damage fibroblasts. A 15-minute exposure to 10% PVP-I was found
to kill 100% of human fibroblasts, and concentrations as low as 1% PVP-I were toxic.13
In this study, bacitracin was not toxic to fibroblasts. Balin and Pratt14 further demonstrated
that an even weaker concentration of 0.1% PVP-I completely inhibited growth of adult skin
fibroblasts. Fibroblast effects also were evident in human donor corneas decontaminated
with concentrations higher than 0.5% PVP-I after a 2-minute soaking time.15 Moreover,
higher PVP-I concentrations and longer soaking times were not completely effective in
eliminating contaminates.
Because of its toxicity to osteoblasts and fibroblasts, as well as doubts about its an-
timicrobial effectiveness, PVP-I does not seem to be the best option for autograft decon-
tamination. If it is used, a low concentration may be preferable.
Antibiotic solutions
Antibiotic solution was the second most commonly used method of decontamination, re-
ported by 50% of survey respondents. They were not asked to specify the antibiotic, but
multiple solutions have been tested in investigational studies. The safety of antibiotics for
irrigationanddecontaminationofvarioustissuetypesiswidelyaccepted.Asexamples,bac-
itracinhasbeenestablishedassafe,3,11,12 ashaverifampicin4 (Rifadin)andthecombination
of neomycin–polymyxin B.5 There is less agreement about effectiveness. Cephalosporins
have been popular decontamination solutions,16 although their efficacy is not impressive
and they are therefore not recommended by some investigators.4,7
Bhandari et al,11 who used 2-, 5-, and 10-minute soak times in bacitracin, found it to
be the least effective of decontamination solutions they tested except for normal saline. An
investigation that exposed patellar tendon allografts to an OR floor for 3 minutes and then
soaked them in a bacitracin–Polymyxin B sulphate solution for 15 minutes determined that
30%ofthegraftscultures’resultswerepositive.3 Theprincipalbehindusingacombination
antibiotic solution is to broaden the spectrum of microbial coverage because grafts may be
contaminated by a variety of organisms.
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Chlorhexidine gluconate
Several studies recommended CHG as the preferred decontamination agent. For ex-
ample, an investigation of human anterior cruciate ligament grafts dropped on an
OR floor for 15 seconds found that 4% CHG had the greatest sterilization im-
pact, with only 2% (1 of 50) of the autografts remaining cultures’ results were pos-
itive after a 90-second soak.5 This was compared to 6% for neomycin/Polymyxin
B sulphate solution and 24% for PVP-I. In a study of harvested cadaveric skin
grafts, there was a significantly diminished bacterial contamination rate (12% with
PVP-I vs 2% with CHG) and the presence of fewer culture-positive species with
CHG.17
An investigation by Goebel and colleagues10 inoculated rabbit patellar tendon-bone
grafts with 2 different Staphylococcus species, then soaked the grafts for 30 minutes in 1 of
3 antimicrobial solutions, followed by a brief saline rinse.10 The gentamicin-clindamycin-
polmyxinsolutionandthePVP-Iwereboth100%ineffectivefordecontaminatingthegrafts,
but 4% CHG killed 100% of the Staphylococcus species. A second phase of this study
determinedthata30-minutesoakin4%CHGsuccessfullydecontaminatedgraftsinoculated
with Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus,o rEnterococcus
faecalis.Thetripleantibioticsolutionwasmoreeffectivefordecontaminatinggraftsexposed
to Klebsiella pneumoniae.
Burd and colleagues18 confirmed Goebel’s findings for tensor fascia lata and Achilles
tendon-calcaneus grafts in humans. Low-power irrigation with 1 L or3Lo fagentamicin-
clindamycin-polmyxin solution did not decontaminate the grafts, nor did benzalkonium
chloride or castile soap. Some cultures’ results were positive after 1 L of irrigation with
CHG, but 3 L of 4% CHG completely disinfected all tissues, even those inoculated with K
pneumoniae. The experiment was repeated using a 2% CHG solution, which was equally
effective.18 TheuseofpowerirrigationratherthanabathreducedtheCHGdecontamination
time to less than 12 minutes (in comparison with 30 minutes in the Goebel study).
Although Burd’s experiments determined that concentrations of CHG less than 2%
were not effective, another investigation found that 0.05% CHG delivered by pressurized
jet lavage for 1 minute followed by a 1-minute saline rinse successfully removed 99.8% of
contaminatingbacteriaonratcartilagewithoutdamagingitsmetabolicactivity.19 Thesafety
of CHG for cartilage also has been demonstrated through daily intraarticular injections of
4% CHG into rabbit knees for 5 days. After this lengthy exposure, no histologic changes
were detected in the cartilage in comparison with noninjected controls.16
Only 1 surgeon who responded to the survey reported using CHG for a contaminated
graft. Yet, the effective decontamination potential of CHG has been clearly demonstrated
through in vitro and in vivo investigations of bone-tendon, ligament, cartilage, and skin
grafts. Both PVP-I and CHG are readily available in operating rooms or easy to obtain
quickly. Mixed-drug antibiotic solutions typically must be ordered from the pharmacy,
which can lead to lengthy delays.
Pulse lavage
High- and low-pressure pulse lavage (1–75 psi) have long been recognized as safe and
effectivefordecontaminationofsofttissues.11 However,bonemaybepronetodamagefrom
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lavage, especially high-pressure pulses. A trial involving rats with fresh, noncontaminated
leg fractures found that fractures exposed to high-pressure lavage healed significantly more
slowly than did those receiving bulb irrigation.20 Another study inoculated canine and
human tibiae with S aureaus to study removal of adherent bacteria using sterile saline at
high-pressure versus low-pressure lavage.21 Both high- and low-pressure lavage thoroughly
decontaminated the bone, yet both also caused periosteal separation, and high-pressure
lavage caused cortical fissures and structural defects in the bone.
Another investigation of canine cortical tibiae inoculated with S aureus found that
the bacterial count was reduced significantly more when delivered with low-pressure pulse
lavage for 2 minutes than when washed for 2 minutes.11 There was no significant difference
between wash and lavage when 1% PVP-I and 1% CHG were tested. In addition, low-
pressure pulse lavage with3Lo fsterile saline alone was determined to be more effective
for decontaminating bone allografts exposed to an OR floor than was rinsing with either
cefuroxime (Ceftin) or rifampicin.4
Not only does the literature suggest that high-pressure pulse lavage may be harmful
for bone grafts; high-pressure lavage systems are not always readily available in ORs, nor
do they seem a practical solution for decontaminating the sometimes very small grafts used
in plastic surgery. The addition of low-pressure pulse lavage, however, seems to play an
important role in graft decontamination.
RECOMMENDATIONS
The literature contains many conflicting results about which antimicrobial solution is most
effective,whichconcentrationorvolumeofasolutionisbetter,orhowlonggraftsshouldbe
exposedtoasolution.Onepointisclearthatanautograftcanbecontaminatedintheaverage
ORwithinseconds.Wemustthereforeassumethataclinicalinfectionmayresultfromgraft
contamination, and 3 survey respondents did report infections following contamination
incidents. It is therefore incumbent upon the surgeon to deal with such incidents in an
appropriate manner.
Prevention should be the first priority. The algorithm shown in Figure 2 outlines peri-
operative steps for reducing the chance of graft contamination. The process analysis should
include OR staff members to determine how graft contamination has occurred or might
occur. All OR staff members should be explicitly alerted at the beginning of a case, during
the mandatory “time-out” period, that an autologous graft will be used, and they should be
aware of a graft’s location at all times. To minimize the chances of contamination, place
the graft in a labeled, sterile container with a closed lid, and place it on the widest table
available and away from the table edge or instruments. In addition, limit handling and ex-
changes of a graft between OR personnel to reduce the chance of dropping or exposure to
a nonsterile area. Include the graft in the surgical count during the checkout process when
a surgical technician is relieved, and have the surgical assistant confirm with the surgeon
before discarding any tissue.
The written and verbal informed consent process for a procedure that will employ a
graft seeks permission to harvest. This provides an ideal opportunity to convey the poten-
tial for graft contamination so that patients will be aware, in advance, that accidents can
happen.
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Figure 2. Perioperative auto-
graft harvest algorithm.
The Figure 3 algorithm presents the steps to take if an autograft does become contam-
inated. Before decontamination, culture the graft to find out what organisms might have
contaminated it. Recently, experts have recommended culturing all grafts, including allo-
grafts,beforeimplantationsothatappropriateantibioticscanbeprescribedshouldinfection
develop.22 Include Clostridium in the culture because it has been implicated in deaths of
patients who received tissue bank allografts.23 In addition, the Centers for Disease Control
and Prevention recommends all allografts be sterilized just before implantation.24
We located no studies on the decontamination of fat grafts, but the limited added
morbidityfromharvestingmorefatprecludestheneedfordecontamination.Skin,cartilage,
and composite tissue should be sterilized with at least 1 L of 4% CHG, preferably with low-
pressure pulse lavage. Several studies recommend 3 L of decontamination solution, but this
large volume does not seem necessary for the very small grafts typically used in plastic
surgery. Furthermore, the addition of low-pressure lavage should reduce the need for larger
volumes and for prolonged soaking times. We recommend reharvesting cancellous bone,
but cortico-cancellous bone may be decontaminated with low-pressure lavage and1Lo f
triple antibiotic solution, the only option not found to be cytotoxic to bone. Regardless of
the decontamination agent used, rinse the graft with normal saline as the final step.
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Figure 3. Intraoperative algorithm for contaminated autograft.
Figure 4. Postoperative al-
gorithm for contaminated
graft.
TheFigure4algorithmoutlinesaprocessforpostoperativemanagement.Weadvocate
fulldisclosuretothepatient.Iftheinformedconsentprocessishandledproperly,patientsare
aware of and prepared for the possibility of contamination. Failure to disclose the incident
can increase the likelihood of a malpractice suit.25,26 A focus group of patients identified
what they want to hear following a medical error: full disclosure; clinical impact; causative
factors; methods of future error prevention; and emotional support, including an apology.27
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Many patients cite their desire to prevent similar adverse events as justification for a
malpractice claim,28,29 yet a discussion of ways to prevent future errors is not a routine part
ofdisclosure.30 Therefore,rootcauseanalysisalongwithanincidentreportshouldbepartof
postoperative process for preventing future incidents. Furthermore, engaging in the quality
assurance review process is protected, privileged communication and non-discoverable in
a legal proceeding as a way to encourage well-intentioned healthcare providers to report
adverse events for quality improvement purposes.
CONCLUSION
Typically, incidents of graft contamination are handled according to a surgeon’s personal
preference or a particular institution’s policies. Because our survey results suggest that
autologousgraftcontaminationmaynotbeasrareaswe’dliketobelieve,thisarticleproposes
thegraftdecontaminationproceduresoutlinedinthepresentedalgorithms.Perhaps,themost
important point to emerge from our literature review is that PVP-I is not recommended for
graft decontamination by many investigators. Disclosure, reporting, and privileged quality
improvement should not be overlooked as part of the prevention process.
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